Dumaog, Junalyn R.
HRN: 24-19-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
CEFUROXIME 1.5GM (VIAL)
12/04/2023
12/11/2023
IV
1.5g
Q8hrs
Multiple Soft Tissue Injury
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes